BLACK DIAMOND THERAPEUTICS I's ticker is BDTX and the CUSIP is 09203E105. A total of 89 filers reported holding BLACK DIAMOND THERAPEUTICS I in Q3 2020. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,288 | -43.2% | 449 | 0.0% | 0.00% | – |
| Q2 2023 | $2,267 | -97.2% | 449 | -98.5% | 0.00% | – |
| Q1 2022 | $81,000 | -50.6% | 29,064 | -5.7% | 0.00% | – |
| Q4 2021 | $164,000 | -38.3% | 30,813 | -1.8% | 0.00% | – |
| Q3 2021 | $266,000 | -28.1% | 31,393 | +3.5% | 0.00% | – |
| Q2 2021 | $370,000 | -16.7% | 30,318 | +65.6% | 0.00% | -100.0% |
| Q1 2021 | $444,000 | -28.6% | 18,306 | -5.7% | 0.00% | 0.0% |
| Q4 2020 | $622,000 | +21.0% | 19,411 | +14.1% | 0.00% | 0.0% |
| Q3 2020 | $514,000 | -19.4% | 17,019 | +12.4% | 0.00% | 0.0% |
| Q2 2020 | $638,000 | +112.0% | 15,140 | +25.5% | 0.00% | 0.0% |
| Q1 2020 | $301,000 | – | 12,061 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| NEA Management Company, LLC | 3,449,845 | $104,289,000 | 4.42% |
| Boxer Capital, LLC | 2,014,858 | $60,909,000 | 2.10% |
| RA Capital Management | 2,589,904 | $78,293,000 | 1.43% |
| Artal Group S.A. | 1,521,517 | $45,995,000 | 1.12% |
| Ikarian Capital, LLC | 358,941 | $10,851,000 | 0.78% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 802,511 | $24,260,000 | 0.59% |
| Bellevue Group AG | 1,403,000 | $42,413,000 | 0.59% |
| Logos Global Management LP | 123,465 | $3,732,000 | 0.48% |
| Casdin Capital, LLC | 289,395 | $8,748,000 | 0.39% |
| HighVista Strategies LLC | 16,391 | $496,000 | 0.36% |